Christina Holmes

Christina Holmes

Auto-generated profile, based on publicly available information

Christina Holmes

Department of Chemical and Biomedical Engineering, College of Engineering, Florida A&M University-Florida State University, 2525 Pottsdamer Street, Room A131, Tallahassee, FL 32310, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2007 in Stem Cells
Verified
Journal Article
Closed access
PDF file
CHChristina Holmes
Christina Holmes
WSWilliam L. Stanford
William L. Stanford
Cloned 20 years ago, stem cell antigen-1 (Sca-1) is used extensively to enrich for murine hematopoietic stem cells. The realization that many different stem cell types share conserved biochemical pathways has led to a flood of recent research using Sca-1 as a candidate marker in the search for tissue-resident and cancer stem cells. Although surprisingly little is still known about its biochemical function, the generation and analysis of knockout mice has begun to shed light on the functions of Sca-1 in stem and progenitor cells, demonstrating that it is more than a convenient marker for stem cell biologists. This review summarizes the plethora of recent findings utilizing Sca-1 as a parenchymal stem cell marker and detailing its functional role in stem and progenitor cells and also attempts to explain the lingering mysteries surrounding its biochemical function and human ortholog.Disclosure of potential conflicts of interest is found at the end of this article.

1 June 2015 in The Spine Journal
Verified
Journal Article
Closed access
Benjamin D. ElderBenjamin D. Elder
Benjamin D. Elder
SLSheng-Fu L. Lo
Sheng-Fu L. Lo
CHChristina Holmes
Christina Holmes
CGC. Rory Goodwin
C. Rory Goodwin
TKThomas A. Kosztowski
Thomas A. Kosztowski
TWTimothy F. Witham
Timothy F. Witham

18 April 2016 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
BHBen P. Hung
Ben P. Hung
BNBilal A. Naved
Bilal A. Naved
ENEthan L. Nyberg
Ethan L. Nyberg
MDMiguel Dias
Miguel Dias
CHChristina A. Holmes
Christina A. Holmes
WGWarren L. Grayson
Warren L. Grayson

1 February 2017 in Spine
Verified
Journal Article
Closed access
PDF file
BEBenjamin D. Elder
Benjamin D. Elder
WIWataru Ishida
Wataru Ishida
SLSheng-Fu L. Lo
Sheng-Fu L. Lo
CHChristina Holmes
Christina Holmes
CGC. Rory Goodwin
C. Rory Goodwin
TWTimothy F. Witham
Timothy F. Witham
Retrospective comparative study. To compare clinical and radiographic outcomes between the S2-alar-iliac (S2AI) and the iliac screw (IS) techniques in the adult population and clarify the clinical strength of S2AI screws. S2AI screws have been described as an alternative method for lumbosacropelvic fixation in place of ISs. The S2AI technique has several advantages with lower prominence, increased ability to directly connect to proximal instrumentation, less extensive dissection of tissue, and enhanced biomechanical strength over the IS technique. However, the clinical significance of these advantages remains unclear. A single-center retrospective review of patients who underwent lumbosacropelvic fixation yielded 25 IS group patients and 65 S2AI group patients. Baseline demographic information, postoperative complications, pain and functional outcomes, and screw-related outcomes were collected. The S2AI group had lower rates of reoperation (8.8% vs. 48.0%, P < 0.001), surgical site infection (SSI) (1.5% vs. 44.0%, P < 0.001), wound dehiscence (1.5% vs. 36.0%, P < 0.001), and symptomatic screw prominence (0.0% vs. 12.0%, P = 0.02) than the IS group, whereas rates of L5-S1 pseudarthrosis, proximal junctional failure, and sacroiliac joint pain were similar in both groups. Statistically significant pain relief and functional recovery were achieved in both groups without any significant intergroup differences. On multivariate analyses, age [odds ratio (OR) = 0.91, P = 0.004] and S2AI instrumentation (OR = 0.08, P < 0.001) were protective of reoperation, whereas diabetes mellitus (OR = 10.9, P = 0.03) and preoperative diagnosis of tumor (OR = 12.3, P = 0.04) were associated with SSI, and S2AI instrumentation (OR = 0.09, P < 0.001) was protective of SSI. The use of the S2AI technique over the IS technique was an independent predictor of preventing reoperation and SSI, while achieving similar clinical and functional outcomes. Level of Evidence: 4

1 September 2009 in Biomaterials
Verified
Journal Article
Closed access
AHAnna L. Hillberg
Anna L. Hillberg
CHChristina A. Holmes
Christina A. Holmes
MTMaryam Tabrizian
Maryam Tabrizian

13 May 2015 in Drug Delivery and Translational Research
Verified
Journal Article
Closed access
PDF file
ENEthan Nyberg
Ethan Nyberg
CHChristina Holmes
Christina Holmes
TWTimothy Witham
Timothy Witham
WGWarren L. Grayson
Warren L. Grayson